Webinars

Personalized Antiplatelet Strategies: State of the Art

Chapters

Date: Wednesday, December 19, 2012

Author: Gurbel, Paul A., MD
Director, Sinai Center for Thrombosis Research
Sinai Hospital of Baltimore
Associate Professor of Medicine
Johns Hopkins University School of Medicine
Baltimore, Maryland
  
Also by this Author ▸

Category: CE Credit, Webinar

Description: Paul Gurbel, MD discusses platelet function testing and the continuing personalization of antiplatelet therapies such as clopidogrel, prasugrel and ticagrelor in order to optimize clinical outcomes. Includes several cases. Presented live at the 2012 Case-Oriented Symposium on Bleeding and Thrombosis in Arlington, VA.

Learning objectives — at the conclusion of this program participants will be able to:

• Review the mechanism of action of P2Y12 inhibitors and other antiplatelet drugs
• Review clinical data and relations of platelet function to thrombosis and bleeding

ASCLS P.A.C.E. credits available through April 13, 2013.

Evaluation and P.A.C.E. credit

Related Content

Presentation:
Personalized Cardiac Risk Evaluation: A Focus on Genetics
Superko, H. Robert, MD

Presentation:
Transfusion and Non-transfusion Approaches to Bleeding
Hoffman, Maureane, MD, PhD

Presentation:
aHUS: Facts, Controversies and Treatment Updates
Brophy, Patrick, MD